当前位置:首页 - 行情中心 - 三星医疗(601567) - 财务分析

三星医疗

(601567)

  

流通市值:465.38亿  总市值:468.06亿
流通股本:14.03亿   总股本:14.11亿

三星医疗(601567)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润18.23亿元,每股收益1.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1187751.95万元,未分配利润649174.57万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2130868.58万元,负债943116.63万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入10,433,714,281.296,997,465,533.743,024,788,914.3411,462,508,357.39
营业总成本8,580,662,700.555,848,534,696.672,639,988,293.389,763,004,868.05
营业利润2,076,643,248.421,315,503,309.8432,786,545.032,270,451,511.49
利润总额2,117,707,156.341,358,643,633.59435,218,535.382,262,067,124.43
净利润1,822,779,409.651,154,096,908.48364,343,246.761,920,803,938.46
其他综合收益1,812,403.5810,108,329.32231,698.5432,154,968.92
综合收益总额1,824,591,813.231,164,205,237.8364,574,945.31,952,958,907.38
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计11,269,490,609.4510,396,160,673.0211,885,676,142.712,204,812,164.37
非流动资产合计10,039,195,179.449,650,870,113.559,448,043,337.59,308,210,742.01
资产总计21,308,685,788.8820,047,030,786.5721,333,719,480.221,513,022,906.38
流动负债合计7,704,905,672.717,169,271,906.836,438,238,358.296,837,888,983.63
非流动负债合计1,726,260,609.331,591,059,460.383,573,039,679.023,521,825,496
负债合计9,431,166,282.048,760,331,367.2110,011,278,037.3110,359,714,479.63
归属于母公司股东权益合计11,700,018,960.9411,107,937,760.9511,150,230,331.4611,005,533,096.56
股东权益合计11,877,519,506.8411,286,699,419.3611,322,441,442.8911,153,308,426.75
负债和股东权益合计21,308,685,788.8820,047,030,786.5721,333,719,480.221,513,022,906.38
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计9,788,478,776.795,991,349,951.052,872,763,896.1512,496,555,618
经营活动现金流出小计8,759,266,819.545,731,106,471.942,773,416,514.1410,595,248,630.96
经营活动产生的现金流量净额1,029,211,957.25260,243,479.1199,347,382.011,901,306,987.04
投资活动现金流入小计357,018,810.02271,649,006.38132,663,277.181,244,641,160.22
投资活动现金流出小计997,951,195.98562,278,176.43289,854,432.931,807,379,179.6
投资活动产生的现金流量净额-640,932,385.96-290,629,170.05-157,191,155.75-562,738,019.38
筹资活动现金流入小计991,114,278.7848,180,446.94371,468,985.73,798,002,887.61
筹资活动现金流出小计4,204,190,201.653,670,151,082.05585,263,163.122,623,473,409.68
筹资活动产生的现金流量净额-3,213,075,922.95-2,821,970,635.11-213,794,177.421,174,529,477.93
汇率变动对现金及现金等价物的影响-30,405,018.39-42,687,184.47-16,636,115.33-1,168,356.28
现金及现金等价物净增加额-2,855,201,370.05-2,895,043,510.52-288,274,066.492,511,930,089.31
期末现金及现金等价物余额2,187,484,508.272,147,642,367.84,754,411,811.835,042,685,878.32
最新报告期:2024-11-19
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华安证券谭国超,陈珈蔚1.631.952.332024-11-19
国海证券李航,王刚1.672.132.592024-10-29
国信证券王晓声,王蔚祺1.642.042.532024-10-29
民生证券王班,乐妍希1.632.102.612024-10-26
中金公司曾韬,张一弛1.662.02--2024-10-25
TOP↑